Picture of Samsung Pharm Co logo

001360 Samsung Pharm Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Samsung Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-40,276-25,093-24,812-14,09211,545
Depreciation
Amortisation
Non-Cash Items29,88418,16010,29858.4-24,310
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital25.92,012-15,057-5,3851,275
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-7,163-1,914-27,657-17,295-10,051
Capital Expenditures-4,065-3,035-12,780-381-12,764
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items23,05115,85910,143-21,957572
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities18,98512,824-2,636-22,338-12,192
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-12,212-1,005-1,42342,71526,025
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-3479,889-31,7053,1053,780